Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04822753 · ClinicalTrials.gov registry record · NA
Platelet Rich Plasma (PRP) for Facet Mediated Lumbar Low Back Pain
A NA study of Facet Joint Pain; Low Back Pain, sponsored by Womack Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT04822753: Completed NA study of Facet Joint Pain; Low Back Pain, sponsored by Womack Army Medical Center.
NCT04822753 is a NA study of Facet Joint Pain; Low Back Pain that has completed, run by Womack Army Medical Center. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04822753, a NA study of Facet Joint Pain; Low Back Pain, has completed, sponsored by Womack Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
Low back pain (LBP) is both the single most common cause of disability and the leading cause of visits when military personnel go to their primary care doctors. Military personnel that deal with LBP can often be placed on limited duty profile. Not surprisingly, the direct and indirect costs of low back and neck pain accounts for approximately $88 billion of health care expenditure. In order to reduce the large financial and personal cost, clinical studies must be designed to treat LBP. This study will provide evidence-based medicine on a new regenerative medicine treatment option that may significantly affect military personnel with LBP. PRP (Platelet Rich Plasma) may offer alternate treatment methods that may help preserve the facet joint structures, and improve pain and function without causing destructive lesions or worsening degenerative joints. This healing process may favor improved participation with rehabilitation therapy and ultimately improve return to duty status. This study will also assess the effectiveness of point of care generated PRP, as a minimally invasive treatment option for treating lumbar facet pain. Specifically, PRP effectiveness will be compared to injecting placebo control when injected into facet joints.
Primary Outcome
Assesses average daily pain on a scale from 0-10
Conditions Studied
Interventions
- PROCEDURE Platelet Rich Plasma injection to the lumbar facet joint
Study Locations (1)
North Carolina
- Womack Army Medical Center - Fort Liberty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2025-06-23 |
| Phase | NA |
What the finished NCT04822753 record still lists
NCT04822753 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Facet Joint Pain; Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Platelet Rich Plasma injection to the lumbar facet joint is the first listed.
NCT04822753 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04822753 about?
NCT04822753 is a clinical study titled "Platelet Rich Plasma (PRP) for Facet Mediated Lumbar Low Back Pain". Low back pain (LBP) is both the single most common cause of disability and the leading cause of visits when military personnel go to their primary care doctors. Military personnel that deal with LBP can often be placed on limited duty profile. Not surprisingly, the direct and indirect costs of low b...
What is the current status of trial NCT04822753?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2021-09-29. Estimated completion is 2025-06-23.
What conditions does trial NCT04822753 study?
This clinical trial studies the following conditions: Facet Joint Pain; Low Back Pain.
What interventions are being tested in trial NCT04822753?
The interventions under investigation include: Platelet Rich Plasma injection to the lumbar facet joint (PROCEDURE).
Who is sponsoring clinical trial NCT04822753?
This trial is sponsored by Womack Army Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04822753 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04822753's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI